Trials / Sponsors / Sameek Roychowdhury
Sameek Roychowdhury
Academic / Other · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer AJCC v8 | Phase 2 | 2025-08-26 |
| Completed | Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations Advanced Malignant Solid Neoplasm, Cholangiocarcinoma, Metastatic Malignant Solid Neoplasm | Phase 2 | 2020-01-16 |
| Withdrawn | Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Ca Advanced Malignant Neoplasm, ALK Fusion Protein Expression, ALK Gene Amplification | Phase 2 | 2019-03-20 |
| Completed | Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Gene Malignant Neoplasm | Phase 2 | 2015-02-24 |